Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Small Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Glioblastoma 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Urinary Bladder Neoplasms 1 Solid Tumor 1 Peripheral Nervous System Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 NSCLC 1 Myeloproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid 1 Leukemia 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Glioma 1 Gastrointestinal Stromal Tumors 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Injections 24 pembrolizumab 13 toripalimab 12 tislelizumab 9 Gemcitabine 7 Cisplatin 7 Carboplatin 6 atezolizumab 5 Nivolumab 5 Irinotecan 5 Pemetrexed 4 Oxaliplatin 4 Leucovorin 4 Fluorouracil 4 Docetaxel 4 Cetuximab 4 trastuzumab deruxtecan 3 spartalizumab 3 cediranib 3 Paclitaxel 3 PM 01183 3 Capecitabine 3 sintilimab 2 olaparib 2 lenvatinib 2 glumetinib 2 camrelizumab 2 apatinib 2 Therapeutics 2 Midazolam 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Solid Tumor × BID protein, human × Clear all

NCT06560632 2026-01-16

POLAR

Repare Therapeutics

Phase 1 Terminated

26 enrolled 14 charts

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡